Resources Contact Us Home
Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Image Number 12 for United States Patent #5609869.

Hybrid immunoglobulin-enzyme molecules are provided which are composed of antibodies, or derivatives or fragments thereof, which specifically bind an arterial or venous thrombus that are operably linked to the enzymatically active portions of thrombolytic enzymes such as plasminogen activators. In a preferred embodiment the hybrid molecules specifically bind to fibrin and have fibrinolytic activity. The hybrid molecules of the present invention may be produced by any means, including chemical conjugation, or by means of recombinant DNA, genetic engineering and/or hybridoma technology. Methods for making and using the molecules in diagnosis and therapy are also disclosed.

  Recently Added Patents
Clock generator circuit for a charge pump
Load control device
User interfaces
System, method, and computer program product for identifying unwanted data communicated via a session initiation protocol
Digital-to-analog converter and performing method thereof
Portable computer
Data processing apparatus and data processing method for reducing an uneven color made up of two or more ink colors
  Randomly Featured Patents
Method of administering intravenous drug using rate-controlled dosage form
Gamma-ketoacid tetrapeptides as inhibitors of caspase-3
In-situ method for determining pore size distribution, capillary pressure and permeability
Pressure-contact joint connector
Activation treatments in plating processes
Method of treating HIV-1 with .alpha.-substituted benzenemethanamine derivatives
Process for removing residues from gas electrodes
Method of treating natural or synthetic polyamide fibre materials
Process for the preparation of 4,4-dimethyl-1-(p-chlorophenyl)pentan-3-one
Real time push notification in an event driven network